MEROPENEM 1gm. IP

A carbapenem antibiotic that fights against aerobic and anaerobic bacteria implicated in serious infections. (S M Holliday, 1998) Holds a powerful antibacterial activity with a broad antibacterial spectrum. (F Hou, 2001) A bactericidal agent that treats life-threatening infections in critically ill patients. (Uwe Liebchen, 2021) An important option for the treatment of serious bacterial infections in hospitalized patients. (Claudine M Baldwin, 2008) A well-tolerated medicine as that of imipenem/cilastatin for the treatment of serious bacterial infections. (F Colardyn, 1996) An effective and safe treatment for bacterial infections caused mainly by beta-lactamase-producing strains. (Fang Hou, 2002) A promising approach for lower respiratory tract infections, urinary tract infections, and other infections caused by beta-lactamase-producing strains. (F Hou, 2001) More active than ceftazidime, gentamicin or ciprofloxacin, against gram-positive aerobes. An effective treatment option for Pseudomonas species infections in patients with cystic fibrosis. (George G Zhanel, 1998) Has a lower likelihood of causing seizures than imipenem for the treatment of meningitis. (George G Zhanel, 1998) Exhibits greater efficacy than ceftazidime plus amikacin or tobramycin in nosocomial pneumonia subjects. (Claudine M Baldwin, 2008)